Numerus Ltd. offers:Clinical Development: Maximise your trial's chances of success. Numerus provides expert statistical services covering design, analysis and reporting of phase I to III trials for drugs and medical devices, including quality reviewed, validated interim analyses for DMC/DSMBs. Health Technology Assessment: Health Technology Assessment (HTA) is surrounded by uncertainty and payers demand robust analyses and a convincing health economic cornerstone, both of which require sound statistical principles. Numerus helps clients prove added value for both drugs and medical devices. Observational Research: With the knowledge and experience to deliver tailored solutions that maximise the full potential of data from uncontrolled observational clinical trials, Numerus excels in helping clients understand the true benefit of their drug in the real world.